KURA:NASDAQ - KURA ONCOLOGY - Cancer biopharmaceutical company
KURA is up 500% from its March lows and running well. It has had a pullback and recovery and then an additional momentum bump on earnings. Could be worth a watch.
NOT TRADING ADVICE. ALWAYS DO YOUR OWN RESEARCH.
FIND TRAILING STOPS: SuperTrail.io
FIND COINS BREAKING OUT: CoinRaces.cc
MY YOUTUBE TRADINGVIEW TIPS AND TRICKS: bit.ly/3kRW08o
MEXC FOR CRYPTO: bit.ly/47QCeNR
FIND TRAILING STOPS: SuperTrail.io
FIND COINS BREAKING OUT: CoinRaces.cc
MY YOUTUBE TRADINGVIEW TIPS AND TRICKS: bit.ly/3kRW08o
MEXC FOR CRYPTO: bit.ly/47QCeNR